These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33139779)

  • 1. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.
    Lehman HL; Kidacki M; Stairs DB
    Sci Rep; 2020 Nov; 10(1):18829. PubMed ID: 33139779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation.
    Lehman HL; Kidacki M; Warrick JI; Stairs DB
    Oncotarget; 2018 Feb; 9(13):11180-11196. PubMed ID: 29541406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma.
    Lehman HL; Yang X; Welsh PA; Stairs DB
    Am J Pathol; 2015 Jan; 185(1):240-51. PubMed ID: 25529795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p120ctn causes EGFR-targeted therapy resistance and failure.
    Landmesser ME; Raup-Konsavage WM; Lehman HL; Stairs DB
    PLoS One; 2020; 15(10):e0241299. PubMed ID: 33112928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
    Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
    Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
    Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
    Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma.
    Chen T; Wang C; Wu F; Zhang X; Yang H; Deng X; He Q; Li W; Li G
    PLoS One; 2015; 10(3):e0118645. PubMed ID: 25785604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
    Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
    Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.
    Fardi Golyan F; Forghanifard MM
    Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma.
    Chung Y; Lam AK; Luk JM; Law S; Chan KW; Lee PY; Wong J
    Ann Surg Oncol; 2007 Nov; 14(11):3260-7. PubMed ID: 17647062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p120-catenin modulates airway epithelial cell migration induced by cigarette smoke.
    Zhang L; Gallup M; Zlock L; Finkbeiner W; McNamara NA
    Biochem Biophys Res Commun; 2012 Jan; 417(1):49-55. PubMed ID: 22120634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
    Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
    Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
    Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
    Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness.
    Golyan FF; Abbaszadegan MR; Forghanifard MM
    J Cell Biochem; 2019 Sep; 120(9):14838-14846. PubMed ID: 31016793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration.
    Feng Z; Li X; Qiu M; Luo R; Lin J; Liu B
    Cancer Biother Radiopharm; 2020 Feb; 35(1):66-71. PubMed ID: 31702393
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma.
    Meng J; Zhang C; Zhao T; Shi G; Zhao J; Lin Z
    Thorac Cancer; 2021 Mar; 12(6):932-940. PubMed ID: 33538099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
    Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
    Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.